Orion Oyj

ORINF · OTC

Market closed$82.75$0.00 (0.00%)After hours $82.75 · 0.00%

Chart data is refreshing.

Key statistics

Previous close$82.75
Open$82.75
Day high$82.75
Day low$82.75
52-week high$82.75
52-week low$48.65
Market cap11.66B
Volume100.00
Average volume91.00
P/E ratio18.79
Forward P/E
EPS4.41
Dividend yield+2.22%

Market context

Why it moved

ORINF showed no significant price movement today, with shares remaining flat as trading volume was negligible and no material company-specific news or broader market catalysts emerged to drive directional activity.

What is happening

Recent company-specific developments and publisher coverage.

ad-hoc-news.de · July 20, 2026Orion stock trades steady as investors weigh recent earnings and pipeline spendingSimply Wall Street · July 19, 2026Orion Oyj (HLSE:ORNBV) Stock Q2 Margin Strength Tests Cautious Growth Narrativesad-hoc-news.de · July 19, 2026Orion stock trades steady as recent quarterly earnings highlight solid pharmaceutical marginsSeeking Alpha · July 18, 2026Orion Oyj 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:ORINF) 2026-07-17Smartkarma · July 18, 2026Orion Oyj (ORNBV) Earnings: Forecast Revision and Strong Q2 Results Drive Stock UpwardInvesting.com South Africa · July 17, 2026Earnings call transcript: Orion tops Q2 2026 expectations, shares jump 11% By Investing.comwww.marketscreener.com · July 17, 2026Orion Oyj Revises Earnings Guidance for the Full Year 2026www.marketscreener.com · July 17, 2026Orion Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
Mt Newswire · June 30, 2026Orion Signs Marketing Deal for Shilpa Medicare's Cancer Therapy Biosimilar in Europe
Mt Newswire · June 16, 2026Digia Unit to Provide Data Integration, AI Analytics for Finnish Health Sector Project
Mt Newswire · June 1, 2026Orion's Solid Tumours Treatment Shows Early Efficacy, Favorable Safety Profile in Phase 1/2 Trial
Mt Newswire · April 23, 2026Orion Raises FY26 Net Sales, Operating Profit Outlook
Mt Newswire · January 15, 2026OP Corporate Bank Downgrades Orion to Accumulate, Raises PT
Mt Newswire · January 14, 2026Orion Estimates to Hit Annual Net Sales Target for Nubeqa by Decade-end
Mt Newswire · January 14, 2026Orion Forecasts Net Sales Growth for FY26
Mt Newswire · December 3, 2025Orion Lifts FY25 Outlook on Expectation of Milestone Payment for Prostate Cancer Drug

Peers